✦ LIBER ✦

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer

✍ Scribed by Songwen ZHOU; Shengxiang REN; Lianghua YAN; Ling ZHANG; Liang TANG; Jie ZHANG; Caicun ZHOU

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib in a previously treated advanc

✍ C. Gridelli; A. Rossi; P. Maione; C. Ferrara; F. Del Gaizo; D. Nicolella; C. Gue 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 91 KB

Clinical retrospective analysis of erlot

✍ Marco Platania; Francesco Agustoni; Barbara Formisano; Milena Vitali; Monika Duc 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 101 KB

Clinical effect of erlotinib as first-li

✍ Xin-Hua Xu; Jin Su; Xiang-Yang Fu; Feng Xue; Qiao Huang; Dao-Jun Li; Ming-Qian L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 232 KB

Clinical observation of docetaxel in tre

✍ Yongguang Cai; Xin Xie; Ming Li 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 230 KB

Phase II study of continuous daily sunit

✍ Novello, S; Scagliotti, G V; Rosell, R; Socinski, M A; Brahmer, J; Atkins, J; Pa 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 304 KB

Clinical benefits as endpoints in advanc

✍ Dong Xue; Ping-ping Li 📂 Article 📅 2011 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 279 KB